Abstract
A robust and safe industrial process, including five isolations and drying steps for widely prescribed anti-HIV (protease inhibitor) drug darunavir ethanolate 2, has been developed. A salient feature of this process is the development of procedures enabling the efficient synthesis of multi-kilogram quantity of darunavir ethanolate, and process demonstrations through plant scale preparation are offered where darunavir molecule has been prepared with overall > 70% chemical yield and > 99.8% purity without involving any purification procedure(s), with all possible process impurities below than the desired limit (not more than 0.08%) were isolated, synthesized and characterized. The developed process is entirely robust, very efficient and demonstrated up to kilograms scale.
Similar content being viewed by others
Notes
References
J.E. Arts, J.D. Hazuda, Cold Spring Harb Perspect Med 2, a007161 (2012)
M. Mahdi, Z. Szojka, J.A. Mótyán, J. Tozsér, Viruses 7, 6152 (2015)
N. Kumarasamy, A. Patel, S. Pujari, Indian J. Med. Res. 134, 787 (2011)
Centers for Disease Control and Prevention (2012, November 30). Vital signs: HIV infection, testing, and risk behaviors among youths - United States. Morbidity and Mortality Weekly Report (MMWR) 61(47), pp. 971–976
M.R. Ghante, R.S. Shelar, S.D. Sawant, M.M. Kadam, Int. J. Pharm. Pharm. Sci. 6, 240 (2014)
M.L. Vazluez, R.A. Mueller, J.J. Talley, D.P. Getman, G.A. DeCrescenzo, J.N. Freskos, R.M. Heintz, D.E. Berternshaw, U.S. Patent RE 42,889 E, 2011
A.N. Kobe, T.S. Akashi, H.M. Takasago, K.I. Kakogawa, N.Y. Matsubara, U.S. Patent 5,929,284, 1999
N.M.F. Goyvaerts, P.T.B.P. Wigerinck, H.B. Zinser, B.M. Ebert, U.S. Patent 7,772,411 B2, 2010
A.K. Ghosh; G.M. Bilcer, T. Devasamudram, U.S. Patent 7,897,635 B2, 2011
P.T.B.P. Wigerinck, D.L.N.G. Surleraux, W.G. Verschueren, H.A. DeKock, W.A.A. Aelterman, U.S. Patent Appl. 2011/0160468 A1, 2011
M. Mizhiritskii, E. Marom, U.S. Patent Appl. 2012/0296101 A1, 2012
K.R. Babu, V.K. Rao, C.N. Raju, Der Pharma Chem. 3, 389 (2011)
A.K. Ghosh, S. Leshchenko, M. Noetzel, J. Org. Chem. 69, 7822 (2004)
M.L. Vazluez, R.A. Mueller, J.J. Talley, D.P. Getman, G.A. DeCrescenzo, J.N. Freskos, R.M. Heintz, D.E. Berternshaw, U.S. Patent 6,248,775 B1, 2001
Q.P.J.L. Mario, K.B.R. Romanie, V.R. Jan, L.C.S. Maria, K.J.H.M. Hero, L.F.A. Marie, Patent EP 1732931 B1, 2016
H.W.P. Vermeersch, D.J.C.T. Thone, D.V. Marie-Louise, U.S. Patent 7,700,645 B2, 2010
H. Singh, T.G. Varadaraju, S. Shah, S.R. Kola, P.K. Sahu, V.G. Regula, V.R. Rayavarpu, P. Kumar, S.K. Dubey, Indian Patent 2451/CHE/2014 A, 2016
S.M. Kelly, B.H. Lipshutz, Org. Lett. 16, 98 (2014)
D.C. Gowda, B. Mahesh, S. Gowda, Indian J. Chem. 40B, 55 (2001)
D.C. Gowda, S. Gowda, Indian J. Chem. 42B, 180 (2003)
H. Chen, C.N. Nilsen, A. Choudhury, K.L. Sorgi, Arkivoc 14, 1 (2008)
J.A. Mangravite, J. Chem. Educ. 60, 439 (1983)
D.C. Gowda, S. Gowda, Indian J. Chem. 39B, 70 (2000)
H.D. Burge, D.J. Collins, Ind. Eng. Chem. Prod. Dev. 19, 389 (1980)
I. Pogorelic, M. Filipan- Litvic, S. Merkas, G. Ljubic, I. Cepanec, M. Litvic, J. Mol. Catal. A: Chem. 274, 202 (2007)
M. Srinivasan, A. Yurek-George, A. Ganesan, Mol. Divers. 9, 291 (2005)
A. Isidro- Llobet, M. Alvarez, F. Albericio, Chem. Rev. 109, 2455 (2009)
D.S. Coffey, M.N. Hawk, S.W. Pedersen, S.J. Ghera, P.G. Marler, P.N. Dodson, M.L. Lytle, Org. Process Res. Dev. 8, 945 (2004)
M. Mizhiritskii, E. Marom, U.S. Patent Appl. 20120296101 A1, 2012
V. Ahire, S. Sasne, A. Deshmukh, K. Kumbhar, A. Bhatnagar, D. Verma, R. Vyas, G. Singh, N. Bhise, U.S. Patent Appl. 20120237770 A1, 2012
P. Kar, R. Lipowsky, V. Knecht, J. Phys. Chem. B. 117, 5793 (2013)
E. Marom, U.S. Patent Appl. 20120035142 A1, 2012
M. Chen, Family Health International Biostatistics Workshop (New Delhi, India, 2007)
Acknowledgements
The authors greatly appreciate financial support for this work from Micro Labs Ltd., API Division Centre, ML-27, Bangalore. We thank our group colleagues for their appreciated contribution. The Analytical Department of Micro Labs Limited acknowledged for providing support for analytical and spectral data.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declared that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Girigani, S., Singh, H., Kola, S.R. et al. An improved and robust scale-up process aided with identification and control of critical process impurities in darunavir ethanolate. Res Chem Intermed 46, 267–281 (2020). https://doi.org/10.1007/s11164-019-03948-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-019-03948-4